2020

---

January 7, 2020
Stephanie Dougan, PhD
Dana-Farber Cancer Institute | Boston, MA
“T Cell Dependent Reprogramming of Myeloid Cells in Tumors”
Host: Kai Wucherpfennig, MD, PhD
View Presentation Here

January 14, 2020
Peter Sicinski, MD, PhD
Dana-Farber Cancer Institute | Boston, MA
“Targeting Cell Cycle Machinery in Cancer”
Host: David Pellman, MD
View Presentation Here

January 14, 2020
Michael Sadelain, MD, PhD
Memorial Sloan-Kettering Cancer Center | New York
“CD19 CARs: The First Synthetic T Cell Response”
Host: Jean Zhao, PhD
View Presentation Here

February 4, 2020
Frederick W. Alt, PhD
Boston Children's Hospital | Boston, MA
“CTCF Orchestrates Long Range Cohesion-Driven V(D)J Recombinational Scanning”
Host: Thomas Look, MD
View Presentation Here

February 11, 2020
William Kaelin, MD
Dana-Farber Cancer Institute | Boston, MA
“The von Hippel-Lindau Hereditary Cancer Syndrome: Bedside to Bench to Bedside”
Host: Julie-Aurore Losman, MD, PhD
View Presentation Here

February 25, 2020
Vishva M. Dixit, MD
Genentech, Inc. | San Francisco, CA
“Shedding Light on Ubiquitin Modification in Cancer”
Host: Anthony Letai, MD, PhD
View Presentation Here

March 3, 2020
Bradley Pentelute, PhD
Massachusetts Institute of Technology | Boston, MA
“Chemistry matched with Mechanical and Computational Machines for Rapid Synthesis and Delivery of Proteins”
Host: Rameen Beroukhim, MD, PhD
View Presentation Here

**COVID-19 SHUT DOWN**

---